Long-term benefits from selective dorsal rhizotomy in a young patient with cerebral palsy
More details
Hide details
Cardiology Clinic of Physiotherapy Division of the 2nd Faculty of Medicine, Medical University of Warsaw, Warsaw, Poland
Mazovian Neurorehabilitation and Psychiatry Center, Rehabilitation Department, Zagórze, Poland
Department of Physiology, Faculty of Rehabilitation, Józef Piłsudski University of Physical Education in Warsaw, Poland
Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland
Submission date: 2016-08-08
Acceptance date: 2016-11-21
Online publication date: 2016-12-06
Publication date: 2020-03-22
Corresponding author
Mariusz Pawłowski   

Cardiology Clinic of Physiotherapy Division of the 2nd Faculty of Medicine, Medical University of Warsaw, Szpital Bielański, Cegłowska 80, 01-809 Warsaw, Poland. Tel.: +48 22 569 02 92; fax: +48 22 569 02 92; mobile: +48 796 062 122.
Pol. Ann. Med. 2017;24(2):256-260
Spasticity is considered to be one of the most important factors hampering functional abilities among patients with a cerebral palsy (CP).

The aim of the study was to present results of the selective dorsal rhizotomy (SDR) procedure combined with the physiotherapy process in a 3 year follow-up study, presented from a functional and structural perspective

Case study:
After the diagnosis of CP in the form of spastic diplegia, the 2-years-old patient (GMFCS 4) was directed for a comprehensive rehabilitation. After clinical examination and family consultation, spasticity was found to be important factor limiting patient functional abilities.

Results and discussion:
The patient was directed to SDR operation. The patient was evaluated four times: before the SDR, and then 1, 2 and 3 years after the SDR surgery. The spasticity was assessed using the modified Tardieu scale. A functional assessment was done using the gross motor function measure (GMFM) scale, 6-min walk test and functional assessment questionnaire (FAQ-10). Amuscle tension remained decreased throughout the 3 years of the follow up period. The achieved reduction in muscle tone was accompanied by a change in a range of motion, an improvement in GMFM total score result, an increased distance in 6-min walk test and in the FAQ-10 questionnaire.

SDR procedure combined with comprehensive rehabilitation programs leads to short- and long-term reduction in the spasticity of a 5-year-old boy with a spastic diplegia. Decreased level of spasticity was accompanied by an increased gross motor functioning and mobility.

None declared.
Koman LA, Smith BP, Shilt JS. Cerebral palsy. Lancet. 2004;363(9421):1619–1631.
Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. 2002;44(9):633–640.
Novak I, Hines M, Goldsmith S, Barclay R. Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics. 2012;130(5):e1285–e1312.
Nelson KB, Blair E. Prenatal factors in singletons with cerebral palsy born at or near term. N Engl J Med. 2015;373(10):946–953.
Yager JY. Animal models of hypoxic–ischemic brain damage in the newborn. Semin Pediatr Neurol. 2004;11(1):31–46.
Volpe J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res. 2001;50(5):553–562.
Smith LR, Chambers HG, Lieber RL. Reduced satellite cell population may lead to contractures in children with cerebral palsy. Dev Med Child Neurol. 2013;55(3):264–270.
Edwards AD, Azzopardi D. Therapeutic hypothermia following perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed. 2006;91(2):F127–F131.
Azzopardi D, Robertson N, Cowan F, et al. Pilot study of treatment with whole body hypothermia for neonatal encephalopathy. Pediatrics. 2000;106(4):684–694.
Cans C, McManus V, Crowley M, et al. Cerebral palsy of postneonatal origin: characteristics and risk factors. Paediatr Perinat Epidemiol. 2004;18(3):214–220.
Aisen ML, Kerkovich D, Mast J, et al. Cerebral palsy: clinical care and neurological rehabilitation. Lancet Neurol. 2011;10(9):844–852.
Roberts A. Surgical management of spasticity. J Child Orthop. 2013;7(5):389–394.
Ward AB. Spasticity treatment with botulinum toxins. J Neural Transm. 2008;115(4):607–616.
Grunt S, Fieggen A, Vermeulen R, Becher J, Langerak N. Selection criteria for selective dorsal rhizotomy in children with spastic cerebral palsy: a systematic review of the literature. Dev Med Child Neurol. 2014;56(4):302–312.
Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Child Nerv Syst. 2001;17(1–2):1–18.
Pawłowski M, Gąsior J, Bonikowski M, Dąbrowski M. [Selective dorsal rhizotomy in spasticity treatment of patients with cerebral palsy]. Pol Przegl Neurol. 2016;12(1):46–52 [in Polish].
Steinbok P. Selective dorsal rhizotomy for spastic cerebral palsy: a review. Child Nerv Syst. 2007;23(9):981–990.
McFall J, Stewart C, Kidgell V, et al. Changes in gait which occur before and during the adolescent growth spurt in children treated by selective dorsal rhizotomy. Gait Posture. 2015;42(3):317–322.
Tedroff K, Löwing K, Jacobson D, Åström E. Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy. Dev Med Child Neurol. 2011;53(8):724–729.
Hoon Jr AH, Stashinko EE. Quality of life in adolescents with cerebral palsy. Lancet. 2015;385(9969):670–672.
Vik T, Vatten L, Markestad T, Jacobsen G, Bakketeig LS. Dubowitz assessment of gestational age and agreement with prenatal methods. Am J Perinatol. 1997;14(6):369–373.
Numanoğlu A, Günel MK. Intraobserver reliability of modified Ashworth scale and modified Tardieu scale in the assessment of spasticity in children with cerebral palsy. Acta Orthop Traumatol Turc. 2012;46(3):196–200.
Park TS. Selective dorsal rhizotomy: an excellent therapeutic option for spastic cerebral palsy. Clin Neurosurg. 2000;47:422–439.
Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol. 1999;6(S4):S23–S35.
Boyd RN, Pliatsios V, Starr R, Wolfe R, Graham HK. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol. 2000;42(1):32–41.
Palisano RJ, Hanna SE, Rosenbaum PL, et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther. 2000;80(10):974–985.
Thompson P, Beath T, Bell J, et al. Test–retest reliability of the 10-metre fast walk test and 6-minute walk test in ambulatory school-aged children with cerebral palsy. Dev Med Child Neurol. 2008;50(5):370–376.
Pawłowski M, Gąsior J, Bonikowski M, Dąbrowski M. The use of selected walk tests for gait assessment in children and adolescents with cerebral palsy. Neurol Dziec. 2015;24(49):13–17.
Novacheck TF, Stout JL, Tervo R. Reliability and validity of the Gillette Functional Assessment Questionnaire as an outcome measure in children with walking disabilities. J Pediatr Orthop. 2000;20(1):75–81.
Peacock W, Arnens L. Selective posterior rhizotomy for relief of spasticity in cerebral palsy. S Afr Med J. 1982;62:119–124.
Oki A, Oberg W, Siebert B, Plante D, Walker M, Gooch J. Selective dorsal rhizotomy in children with spastic hemiparesis. J Neurosurg Pediatr. 2010;6(4):353–358.
Mäenpää H, Salokorpi T, Jaakkola R, et al. Follow-up of children with cerebral palsy after selective posterior rhizotomy with intensive physiotherapy or physiotherapy alone. Neuropediatrics. 2003;34(2):67–71.
Farmer J, Sabbagh A. Selective dorsal rhizotomies in the treatment of spasticity related to cerebral palsy. Child Nerv Syst. 2007;23(9):991–1002.
Rosenbaum PL, Palisano RJ, Bartlett DJ, Galuppi BE, Russell DJ. Development of the Gross Motor Function Classification System for cerebral palsy. Dev Med Child Neurol. 2008;50(4):249–253.
Thomas SS, Buckon C, Piatt JH, Aiona MD, Sussman MD. A 2-year follow-up of outcomes following orthopedic surgery or selective dorsal rhizotomy in children with spastic diplegia. J Pediatr Orthop B. 2004;13(6):358–366.
Kim D, Choi J, Yang K, Park C. Selective posterior rhizotomy in children with cerebral palsy: a 10-year experience. Child Nerv Syst. 2001;17(9):556–562.
National Institute for Health and Care Excellence. Selective dorsal rhizotomy for spasticity in cerebral palsy. Accessed 21.11.16.
Crilly M. Selective dorsal rhizotomy remains experimental in cerebral palsy. BMJ. 2012;345:e6670.
Mugglestone M, Eunson P, Murphy M. Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance. BMJ. 2012;345:e4845.
Grunt S, Henneman W, Bakker M, et al. Effect of selective dorsal rhizotomy on gait in children with bilateral spastic paresis: kinematic and EMG-pattern changes. Neuropediatrics. 2010;41(5):209–216.
Langerak N, Lamberts R, Fieggen A, et al. A prospective gait analysis study in patients with diplegic cerebral palsy 20 years after selective dorsal rhizotomy. J Neurosurg Pediatr. 2008;1(3):180–186.
Rosenbaum PL, Walter SD, Hanna SE, et al. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA. 2002;288(11):1357–1363.
Engsberg J, Ross S, Collins D, Park T. Effect of selective dorsal rhizotomy in the treatment of children with cerebral palsy. J Neurosurg. 2006;105(1 suppl):8–15.
Trost J, Schwartz M, Krach L, Dunn M, Novacheck T. Comprehensive short-term outcome assessment of selective dorsal rhizotomy. Dev Med Child Neurol. 2008;50(10):765–771.
Colver A, Fairhurst C, Pharoah PO. Cerebral palsy. Lancet. 2014;383(9924):1240–1249.
Novak I, McIntyre S, Morgan C, et al. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013;55(10):885–910.
Journals System - logo
Scroll to top